Private Trust Company’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $307K | Buy |
5,848
+691
| +13% | +$36.5K | 0.02% | 655 |
|
|
2026
Q1 | $285K | Sell |
5,157
-1,754
| -25% | -$95K | 0.03% | 639 |
|
|
2025
Q4 | $339K | Sell |
6,911
-394
| -5% | -$18.4K | 0.03% | 561 |
|
|
2025
Q3 | $315K | Sell |
7,305
-182
| -2% | -$7.11K | 0.03% | 574 |
|
|
2025
Q2 | $287K | Buy |
7,487
+2,006
| +37% | +$76.7K | 0.03% | 587 |
|
|
2025
Q1 | $212K | Buy |
5,481
+295
| +6% | +$10.8K | 0.02% | 685 |
|
|
2024
Q4 | $175K | Sell |
5,186
-354
| -6% | -$12.7K | 0.02% | 748 |
|
|
2024
Q3 | $226K | Buy |
5,540
+1,768
| +47% | +$72.3K | 0.02% | 651 |
|
|
2024
Q2 | $145K | Sell |
3,772
-1,945
| -34% | -$81.8K | 0.02% | 762 |
|
|
2024
Q1 | $245K | Hold |
5,717
| – | – | 0.03% | 571 |
|
|
2023
Q4 | $212K | Buy |
5,717
+61
| +1% | +$2.19K | 0.02% | 594 |
|
|
2023
Q3 | $205K | Sell |
5,656
-1,419
| -20% | -$50.4K | 0.03% | 560 |
|
|
2023
Q2 | $252K | Sell |
7,075
-104
| -1% | -$3.73K | 0.03% | 490 |
|
|
2023
Q1 | $255K | Buy |
7,179
+1,473
| +26% | +$51.5K | 0.03% | 468 |
|
|
2022
Q4 | $201K | Buy |
+5,706
| New | +$190K | 0.03% | 507 |
|
|
2022
Q3 | – | Sell |
-5,981
| Closed | -$325K | – | 2092 |
|
|
2022
Q2 | $325K | Sell |
5,981
-4,383
| -42% | -$242K | 0.05% | 371 |
|
|
2022
Q1 | $564K | Sell |
10,364
-3,297
| -24% | -$179K | 0.09% | 211 |
|
|
2021
Q4 | $753K | Buy |
13,661
+1,393
| +11% | +$72.5K | 0.1% | 202 |
|
|
2021
Q3 | $586K | Sell |
12,268
-1,250
| -9% | -$62.8K | 0.09% | 243 |
|
|
2021
Q2 | $673K | Sell |
13,518
-608
| -4% | -$29.2K | 0.1% | 212 |
|
|
2021
Q1 | $630K | Buy |
14,126
+979
| +7% | +$44.4K | 0.1% | 211 |
|
|
2020
Q4 | $604K | Sell |
13,147
-422
| -3% | -$19.4K | 0.1% | 220 |
|
|
2020
Q3 | $638K | Buy |
13,569
+5,523
| +69% | +$277K | 0.12% | 180 |
|
|
2020
Q2 | $412K | Buy |
8,046
+680
| +9% | +$34.9K | 0.09% | 245 |
|
|
2020
Q1 | $348K | Sell |
7,366
-40
| -0.5% | -$2.13K | 0.09% | 248 |
|
|
2019
Q4 | $434K | Hold |
7,406
| – | – | 0.08% | 274 |
|
|
2019
Q3 | $395K | Buy |
7,406
+16
| +0.2% | +$823 | 0.08% | 269 |
|
|
2019
Q2 | $369K | Buy |
7,390
+1,683
| +29% | +$84.5K | 0.07% | 269 |
|
|
2019
Q1 | $298K | Buy |
5,707
+160
| +3% | +$8K | 0.06% | 294 |
|
|
2018
Q4 | $264K | Buy |
5,547
+61
| +1% | +$3K | 0.06% | 292 |
|
|
2018
Q3 | $275K | Buy |
5,486
+646
| +13% | +$32.8K | 0.06% | 314 |
|
|
2018
Q2 | $243K | Sell |
4,840
-430
| -8% | -$21.7K | 0.05% | 330 |
|
|
2018
Q1 | $257K | Sell |
5,270
-364
| -6% | -$17K | 0.06% | 317 |
|
|
2017
Q4 | $249K | Sell |
5,634
-724
| -11% | -$33.4K | 0.05% | 322 |
|
|
2017
Q3 | $322K | Buy |
6,358
+129
| +2% | +$6.54K | 0.07% | 293 |
|
|
2017
Q2 | $335K | Sell |
6,229
-293
| -4% | -$15.6K | 0.07% | 289 |
|
|
2017
Q1 | $343K | Sell |
6,522
-233
| -3% | -$11.8K | 0.08% | 282 |
|
|
2016
Q4 | $325K | Buy |
6,755
+500
| +8% | +$24.7K | 0.08% | 261 |
|
|
2016
Q3 | $337K | Buy |
6,255
+355
| +6% | +$19.5K | 0.08% | 254 |
|
|
2016
Q2 | $319K | Buy |
5,900
+1,054
| +22% | +$55.5K | 0.08% | 248 |
|
|
2016
Q1 | $245K | Buy |
+4,846
| New | +$241K | 0.07% | 262 |
|
|
2015
Q4 | – | Sell |
-4,186
| Closed | -$201K | – | 307 |
|
|
2015
Q3 | $201K | Buy |
4,186
+36
| +0.9% | +$1.87K | 0.06% | 299 |
|
|
2015
Q2 | $216K | Sell |
4,150
-69
| -2% | -$3.88K | 0.06% | 301 |
|
|
2015
Q1 | $243K | Buy |
4,219
+367
| +10% | +$21K | 0.07% | 283 |
|
|
2014
Q4 | $205K | Sell |
3,852
-342
| -8% | -$19.1K | 0.07% | 280 |
|
|
2014
Q3 | $241K | Sell |
4,194
-624
| -13% | -$38.3K | 0.08% | 255 |
|
|
2014
Q2 | $322K | Buy |
4,818
+668
| +16% | +$45.2K | 0.1% | 221 |
|
|
2014
Q1 | $277K | Sell |
4,150
-259
| -6% | -$17.5K | 0.1% | 214 |
|
|
2013
Q4 | $294K | Sell |
4,409
-531
| -11% | -$34.4K | 0.12% | 191 |
|
|
2013
Q3 | $310K | Buy |
4,940
+561
| +13% | +$36.1K | 0.14% | 168 |
|
|
2013
Q2 | $274K | Buy |
+4,379
| New | +$278K | 0.13% | 177 |
|
Other funds holding GSK
JEST
Private Trust Company's GSK Position: Q2 2026 in Review
Private Trust Company increased its GSK (GSK) stake by 13% in Q2 2026, buying an estimated $36.5K and bringing the position to 5,848 shares worth $307K. The position accounts for 0.02% of the portfolio, ranked #655.
Private Trust Company first reported a position in GSK in Q2 2013 and has held it in 51 quarters since. The position peaked at $753K in Q4 2021. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.
- Private Trust Company held 5,848 shares of GSK worth $307K as of Q2 2026.
- Private Trust Company bought 691 GSK shares in Q2 2026, an estimated $36.5K.
- GSK made up 0.02% of Private Trust Company's portfolio in Q2 2026, its #655 holding.
- Private Trust Company first reported a position in GSK in Q2 2013 and has held it in 51 quarters since.
- Private Trust Company's GSK position peaked at $753K in Q4 2021.
- 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.
Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.